Geoffrey Beene Foundation Alzheimer’s Initiative Offers Prize for Innovation


The Geoffrey Beene Foundation Alzheimer’€™s Initiative has announced its second online innovation challenge, which seeks to identify differences in early cognitive decline between genders. Winning submissions will share $100,000 in prize awards.

This new initiative ’€” called the 2013 Geoffrey Beene Global NeuroDiscovery Challenge ’€” was announced Monday at the Society for Women’€™s Health Research Gala in Washington, DC.

’€œNot unlike cancer, the Geoffrey Beene Foundation’€™s lead philanthropic cause, most researchers agree that the greatest potential to stop Alzheimer’€™s lies in the earliest stages of the disease, which is why we fund translational research. Innovative Challenges help to support that mission,’€ said Tom Hutton, trustee and CEO of the Geoffrey Beene Foundation and president and CEO of Geoffrey Beene, LLC. ’€œWe must redefine the solutions process and free the greatest minds of our time to do the work to help save and improve lives.’€

Geoffrey Beene also sponsors the Builders of Science Award, one of Research!America’€™s annual Advocacy Awards.

Written proposals must be submitted by August 31. The responses will be judged by a stellar panel of experts, including Marietta Anthony, PhD, former director of women’€™s health programs at the Critical Path Institute; Howard Fillit, MD, of the Alzheimer’€™s Drug Discovery Foundation; Florence Haseltine, MD, PhD, founder of the Society for Women’€™s Health Research; Freda Lewis-Hall, MD, of Pfizer Inc.; Peter Rabins, MD, MPH, of Johns Hopkins Medicine; Alan Russell, PhD, of Carnegie Mellon University; Scott Small, MD, of Columbia University; and Kate Zhong, MD, of the Cleveland Clinic.

As many as five finalists will receive awards of at least $10,000; one of the finalists will then be selected for a $50,000 grand prize to be announced in late fall. Winning entries are eligible for further development and possible implementation of the proposed research in collaboration with the Geoffrey Beene Foundation.

’€œWomen are two times at risk for Alzheimer’€™s because we outlive men, but we know little about other possible male-female differences. It’€™s time to find out if what’€™s true in cardiovascular disease, with different diagnostics and treatment of men and women, is also true for Alzheimer’€™s disease,’€ said Meryl Comer, president and CEO of the Geoffrey Beene Foundation Alzheimer’€™s Initiative.

To learn more, visit the Geoffrey Beene Challenge website or the NeuroDiscovery Challenge webpage.

Post ID: 

Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter